| GUARD THERAPEUTICS INT.AB |
| Schweden |
| Gesundheit |
| SE0021181559 / A3E2EN |
| 5LH0 (Frankfurt) |
| FRA:5LH0, ETR:5LH0, 5LH0:GR |
| - |
| https://guardtherapeutics.. |
|
Guard Therapeutics International AB, a biotechnology company, focuses on developing pharmaceutical treatments for the prevention and management of acute kidney injuries. Its flagship product, RMC-035, is a pioneering drug candidate aimed at reducing ..
>Volltext.. |
| 2.55 Mio. EUR |
| -2.04 Mio. EUR |
| - |
| - |
| -10.2 Mio. EUR |
| -0.61 EUR |
| - |
| 4.67 Mio. EUR |
| -10.25 Mio. EUR |
| 4.93 |
| - |
| -20.07% |
| - |
| - |
| - |
| - |
| GUARD THERAPEUTICS, GUARD THERAPEUTIC |
| 05.04.26 |
|